Detalhe da pesquisa
1.
Nomogram based on baseline clinicopathological characteristics for predicting bladder cancer-specific survival to neoadjuvant chemotherapy in muscle-invasive bladder cancer.
World J Urol
; 40(11): 2627-2634, 2022 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-36107212
2.
Development and Independent Validation of a Prognostic Gene Expression Signature Based on RB1, PTEN, and TP53 in Metastatic Hormone-sensitive Prostate Cancer Patients.
Eur Urol Oncol
; 2024 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38429210
3.
Curcumin as a hepatoprotective agent against chemotherapy-induced liver injury.
Life Sci
; 332: 122119, 2023 Nov 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37741319
4.
Prevalence of immune-related adverse events and anti-tumor efficacy in advanced/metastatic urothelial carcinoma following immune-checkpoint inhibitor treatment.
Clin Transl Oncol
; 25(12): 3556-3564, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37217634
5.
Transcriptional Profile Associated with Clinical Outcomes in Metastatic Hormone-Sensitive Prostate Cancer Treated with Androgen Deprivation and Docetaxel.
Cancers (Basel)
; 14(19)2022 Sep 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-36230681
6.
Phase 2 Randomized Study of Radiation Therapy and 3-Year Androgen Deprivation With or Without Concurrent Weekly Docetaxel in High-Risk Localized Prostate Cancer Patients.
Int J Radiat Oncol Biol Phys
; 103(2): 344-352, 2019 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30321689